ai sector overviews Articles and Reports
Artificial intelligence “sector overview” reports are designed to help business leaders explore the possibilities and important AI trends across industries. Search our sector overview reports below:
This article was originally written as part of an in-depth AI report sponsored by Iron Mountain, and was written, edited and published in alignment with our transparent Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Thought Leadership Services page.
The business world has been talking about AI for several years now, and it's safe to say that it's reached a certain cultural moment among executives in areas like banking, insurance, and pharma. Government leaders have been much slower to start the conversation around the capabilities of AI, including the possibilities they offer to militaries and the ethical implications of AI when it comes to governance and the legal system.
There are several companies claiming to offer AI-based medical transcription software, specifically speech recognition software, to hospitals and healthcare companies. We found that these solutions are intended to help hospitals and healthcare companies with medical transcription in different forms, transcribing speech into text in order to fill out and update patient medical records in electronic health record (EHR) and electronic medical record (EMR) databases.
Machine Learning for Medical Transcription - Insights Up Front
We can’t seem to find evidence that the prominent companies offering speech recognition software for medical transcription have what we would expect in terms of talent at their company, except for Nuance Communications. It isn’t clear how exactly their solutions could work without natural language processing, a kind of artificial intelligence. Nuance employs many data scientists with PhDs and Master’s degrees in computer science and hard sciences like physics. This is generally what we look for when it comes to vetting a company on their claims to leveraging artificial intelligence and cutting through the marketing hype we so often see on AI vendor websites.
Boeing offers a number of autonomous vehicles to the military, which it claims can help military operators effectively complete both routine and critical missions with less risk of endangering the lives of military operators. In 2017, Boeing Defense, the predominantly non-commercial division of Boeing that focuses on government contracts, reported 29.5 Billion dollars in revenue. This makes it the second largest defense contractor for the US military and the world. Boeing, established in 1916, is a publicly traded company that employs over 120,000 people.
There are several companies claiming to offer AI solutions to healthcare companies, as we've explored extensively in our past reports. In this particular report, we focus on AI as it pertains to working with electronic health records (EHRs) and electronic medical records (EMRs). AI vendors offer solutions to hospitals and clinics with a variety of functions.
According to Accenture, approximately 66% of A&D executives polled indicated they are looking at investing in AI for 2019, particularly on security, production, and R&D. 80% believe that AI-based decisions will have a direct impact on the workforce by 2021.
This report attempts to highlight the wide array of real-world use cases of machine vision in the military. Several militaries claim to leverage machine learning, working with contractors and companies in some cases to deliver AI solutions. We found that these solutions help highlight the wide breadth of current and near-term military applications of machine vision. The companies and organizations discussed in this report help various militaries with at least one of the following:
Accenture reports that in 2017, the 16 top biopharmaceutical companies in the world had an aggregate global revenue of $428 billion, which was nearly half the global pharmaceutical market by net sales. The report also revealed a shift to specialty drugs for hard-to-treat diseases.